Tag Archives: CYTK

Top 10 Value Stocks To Invest In 2018

DryShips (DRYS) finally filed a 6-K after the close on July 25th that provided an update on its equity issuance for the period July 17th to July 25th. This was a break from prior disclosure patterns of providing updates on Fridays after the close or Mondays before the open as discussed in my article titled “Changing Its Disclosure Patterns?” The update on DRYS’ equity issuance was disappointing since the shares issued and the equity raised fell short of my expectations and, judging by the 20% losses in the stock into the late afternoon on July 26th, the market’s also. The following table summarizes the issuance for the period ending July 25th.

DryShips Equity Issuance Analysis Shares O/S July 7th (millions) 5.10 Funding Gap July 14th (millions) $5.56 Dates of Issuance July 17th – July 25th Shares Issued (millions) 14.08 Avg Issuance Price $1.88 July 25th Close $0.96 Shares O/S July 25th (millions) 19.18 Est of Value of Equity Issued $26.49

A close read of the 6-K reveals that most of the 14 million share issuance occurred July 21st through July 25th due to the pendency of the 1 for 7 reverse stock split announced on July 18th with an Effective Date of July 21st. The stock issued during this three day trading period equaled a bit more than 15% of the more than 91 million shares traded. Although this falls within the range of prior issuance percentages, it was a bit surprising that DRYS did not take advantage of the heavy trading volumes and price spikes and drive issuance closer to 20% of the shares traded. This resulted in lower equity proceeds than anticipated.

Top 10 Value Stocks To Invest In 2018: Arena Pharmaceuticals, Inc.(ARNA)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, healthcare shares fell by 0.09 percent. Meanwhile, top losers in the sector included Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), down 6 percent, and Omeros Corporation (NASDAQ: OMER), down 5 percent.

  • [By Paul Ausick]

    Arena Pharmaceuticals Inc. (NASDAQ: ARNA) posted a new 52-week low of $1.20 on Tuesday, down about 19% compared with Monday’s closing price of $1.48. The stock’s 52-week high is $2.16. Volume was about 10% below the daily average of around 3.8 million shares. The company priced a secondary offering of 60 million shares at $1.15 per share, a path guaranteed to enrage existing investors.

  • [By Lisa Levin]

    Shares of Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) were down around 18 percent to $1.22. Arena Pharmaceuticals priced its 60 million share offering at $1.15 per share.

Top 10 Value Stocks To Invest In 2018: JA Solar Holdings, Co., Ltd.(JASO)

Advisors’ Opinion:

  • [By Monica Gerson]

    JA Solar Holdings Co., Ltd. (ADR) (NASDAQ: JASO) is estimated to report its quarterly earnings at $0.68 per share on revenue of $683.29 million.

    Leju Holdings Ltd (ADR) (NYSE: LEJU) is projected to report its quarterly earnings at $0.14 per share on revenue of $194.20 million.

  • [By Travis Hoium]

    Earnings season is about over for the solar industry, and after JA Solar (NASDAQ:JASO) and Vivint Solar (NYSE:VSLR) reported this week, there were a few major takeaways from the end of 2016 and early 2017.

  • [By Elizabeth Balboa]

    First Solar, Inc (NASDAQ: FSLR) was trading down 3.7 percent Monday, while JA Solar Holdings Co., Ltd. (ADR) (NASDAQ: JASO) was down 0.8 percent, SunPower Corporation (NASDAQ: SPWR) 4.4 percent, Canadian Solar Inc. (NASDAQ: CSIQ) 5.2 percent and JinkoSolar Holding Co., Ltd. (NYSE: JKS) 4.4 percent.

Top 10 Value Stocks To Invest In 2018: (PIONF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    International Lithium (ILC) is a small lithium explorer/project generator with four joint venture lithium projects, and one fully-owned lithium project:

    Mariana lithium brine in Argentina (20% ILC: 80% GFL). ILC can increase to 30% via a 10% back-in right. Jiangxi Ganfeng Lithium (GFL) is committed to US$10m in expenditures at Mariana. This is their flagship project. Avalonia lithium pegmatite in Ireland (45% ILC: 55% GFL). GFL has the option to acquire an additional 24% after spending US$10m, or producing a Feasibility Study [FS]. Mavis Lake and Raleigh lithium pegmatite in Ontario Canada (49% ILC: 51% Pioneer Resources Limited (OTC:PIONF)). 100% of the Forgan Lake pegmatite project in Canada.

    Note that Avalon, Mavis Lake, Raleigh, and Forgan Lake also have rare earths. Jiangxi Ganfeng Lithium (SHE:002460) has an 18.1% stake in ILC in addition to the above joint venture partnerships.

Top 10 Value Stocks To Invest In 2018: ThyssenKrupp AG (TYEKF)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    In addition, the company announced that it has agreed to acquire a steel plant in Brazil from ThyssenKrupp (NASDAQOTH:TYEKF) for $1.3 billion. While that plant has had its share of problems in the past, Ternium is getting it for a good value, and it has upside potential. The company paid slightly less than five times EBITDA (earnings before interest, taxes, depreciation, and amortization) for the facility. As the following chart shows, that’s below the value that steel-company stocks trade for these days:

Top 10 Value Stocks To Invest In 2018: Royal Bank Scotland plc (The)(RBS)

Advisors’ Opinion:

  • [By Paul R. La Monica]

    European banks worse off than 2008? Lamensdorf is concerned about the exposure to bad loans (especially energy company debt) held by big banks such as Royal Bank of Scotland (RBS), Credit Suisse (CS) and Deutsche Bank (DB). He’s shorting all three.

  • [By Jonathan Morgan]

    Adidas AG slid 2.9 percent after lowering its profit forecast for 2013. Direct Line Insurance Group Plc lost 2.5 percent as Royal Bank of Scotland Group Plc (RBS) sold a 630 million-pound ($1 billion) stake in the U.K.s biggest car insurer.

Top 10 Value Stocks To Invest In 2018: Barclays PLC(BCS)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    Barclays PLC (NYSE: BCS) was raised to Overweight from Equal Weight at Morgan Stanley. Its American depositary sharesclosed up 2.6% at $11.36 on Thursday and were indicated up 1.2% at $11.50 on Friday. The52-week range is $6.76 to $12.05.

  • [By WWW.THESTREET.COM]

    Banco Santander (SAN) : “I prefer Barclays (BCS) , but let’s wait and see what the other banks have to say”

    ProLogis (PLD) : “I am not a fan of that group right now, but that one is best of breed.”

Top 10 Value Stocks To Invest In 2018: Amgen Inc.(AMGN)

Advisors’ Opinion:

  • [By Todd Shriber, ETF Professor]

    Several big-name biotech companies step into the earnings confessional starting in the middle of the week, with Amgen, Inc. (NASDAQ: AMGN), Anthem Inc (NYSE: ANTM), and Celgene Corporation (NASDAQ: CELG) among the companies in play. That could bring opportunity with the  Direxion Daily S&P Biotech Bull 3X Shares (NYSE: LABU) and the Direxion Daily S&P Biotech Bear 3X Shares (NYSE: LABD).

  • [By Stavros Georgiadis]

    Gilead Sciences (NSDQ:GILD) has underperformed the market with its stock price down almost 25% compared to a 10.33% gain in Nasdaq Composite (INDX:COMPX) and 14.60% gain of Dow Jones Industrial Average (INDX:INDU). Gilead and Amgen (NSDQ:AMGN)have had a very tough year, so it is interesting to know if now is the time to invest in GILD stock, not from a bottom fishing point of investing, which is often too risky, but on some solid financial and fundamentals arguments.

  • [By Ben Levisohn]

    What do I mean? Regeneron’s dropped 14% during the last three months, the result of a patent suit with Amgen(AMGN) over its anti-cholesterol drug Praluent, which a judge had set it wouldn’t be able to sell in the U.S.Then last night, there was finally good news: Ajudge ordered a stay, which would allow Regeneron to sell Praluent, and resulted in a 2% pop in its shares last night after the market close. But then Regeneron reported earnings, and while profits of $3.04 cents a share metthe Street consensus, Regeneron missed on sales and offered disappointing guidance. That caused Regeneron shares to sink 2.1% in pre-open trading.

  • [By Ben Levisohn]

    Regeneron Pharmaceuticals (REGN) tumbled to the bottom of the S&P 500 today after a judge said the company could be forced to stop selling an anti-cholesterol drug due to violating an Amgen (AMGN) patent.

  • [By Tom Gentile]

    After the Senate scored the votes on Tuesday to review a plan for repealing or repealing and replacing what’s come to be known as Obamacare, we saw a mixed-bag reaction from healthcare stocks. Even some of the bulletproof ones, like Amgen Inc. (Nasdaq: AMGN), closed lower from their opening highs.

  • [By Chris Lange]

    Amgen Inc. (NASDAQ: AMGN) is expected to report its most recent quarterly results on Wednesday. The consensus estimates call for $3.00 in EPS and $5.61 billion in revenue. Shares closed trading at $160.41 on Friday, in a 52-week range of $133.64 to $184.21. The consensus price target is $185.13.

Top 10 Value Stocks To Invest In 2018: Jacobs Engineering Group Inc.(JEC)

Advisors’ Opinion:

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Tuesday was Jacobs Engineering Group Inc. (NYSE: JEC) which rose about 9% to $64.92. The stocks 52-week range is $49.31 to $65.29. Volume was1.8 million compared to its average volume of less than 1 million.

  • [By Ben Levisohn]

    Lee offers 22 stocks that could benefit from the correlation trade: Western Digital (WDC), Xerox (XRX), First Solar, Ford Motor, Best Buy (BBY), PulteGroup (PHM), AutoNation (AN), Textron (TXT), Jacobs Engineering Group (JEC), Mosaic, BB&T (BBT), Fifth Third Bancorp (FITB),Loews (L), Regions Financial (RF), KeyCorp (KEY), Comerica (CMA), Leucadia National (LUK), Zions Bancorp (ZION), Valero Energy (VLO), Marathon Oil, Cardinal Health (CAH), and Pepco Holdings (POM).

Top 10 Value Stocks To Invest In 2018: Cytokinetics, Incorporated(CYTK)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Marathon Patent Group Inc (NASDAQ: MARA) shares surged 30.2 percent to $5.01 after dropping 40.86 percent on Tuesday. Marathon Patent Group filed for sale of 1.85 million shares of common stock by selling stockholders.
    Capricor Therapeutics Inc (NASDAQ: CAPR) shares jumped 17.2 percent to $2.25 after the company reported the FDA clearance of Investigational New Drug application for CAP-1002.
    Rite Aid Corporation (NYSE: RAD) gained 13.2 percent to $2.15 following 16.5 percent rally on Tuesday.
    Photronics, Inc. (NASDAQ: PLAB) shares climbed 11.8 percent to $10.45 after the company reported stronger-than-expected earnings for its fourth quarter.
    China Distance Education Hldgs Ltd (ADR) (NYSE: DL) shares surged 11.3 percent to $8.67. China Distance Education reported Q4 profit of $5.9 million on revenue of $41.7 million.
    Cytokinetics, Inc. (NASDAQ: CYTK) shares gained 11 percent to $8.05 after falling 7.05 percent on Tuesday.
    Ooma Inc (NYSE: OOMA) shares surged 8.5 percent to $10.85 as the company posted strong Q3 results.
    Nuance Communications Inc. (NASDAQ: NUAN) climbed 8 percent to $17.12 after the company reported stronger-than-expected results for its fourth quarter on Tuesday.
    American Superconductor Corporation (NASDAQ: AMSC) surged 7.8 percent to $3.59 after the company reported $8 million in D-VAR system orders.
    Thermon Group Holdings Inc (NYSE: THR) rose 6.3 percent to $24.17. William Blair upgraded Thermon Group from Market Perform to Outperform.
    Domino's Pizza, Inc. (NYSE: DPZ) surged 6.1 percent to $182.88. Nomura upgraded Domino's from Neutral to Buy.
    Xencor Inc (NASDAQ: XNCR) rose 5.9 percent to $21.17. Cantor Fitzgerald initiated coverage on Xencor with an Overweight rating.
    Idera Pharmaceuticals Inc (NASDAQ: IDRA) gained 5.1 percent to $2.28 after the company disclosed that it has been granted FDA Fast Track designation for IMO-2125.
    Regal Entertainment Group (NYSE: RGC) gained 5.1 percent to
  • [By Paul Ausick]

    Cytokinetics Inc. (NASDAQ: CYTK) dropped about 37% Tuesday to post a new 52-week low of $7.00 after closing at $11.10 on Monday. The 52-week high is $17.20. Volume was around 7 million, about 14 times the daily average of less than 500,000. The company’s ALS drug failed ti meet its endpoint in a phase 3 study.

  • [By Lisa Levin]

    Cytokinetics, Inc. (NASDAQ: CYTK) shares dropped 27 percent to $8.12 on the back of negative trial results for its amyotrophic lateral sclerosis, or ALS, treatment candidate tirasemtiv in a late-stage study. The results of the international Phase 3 study showed tiraemtive did not meet the primary endpoint of change from baseline in slow vital capacity, or SVS, evaluated at 24 weeks, as well the secondary endpoints evaluated at 48 weeks.

  • [By Chris Lange]

    Cytokinetics, Inc. (NASDAQ: CYTK) saw its shares take a massive step back in Tuesdays session after the firm reported negative results for its trial in amyotrophic lateral sclerosis (ALS). Specifically, the firms Phase 3 clinical trial of tirasemtiv did not meet the primary endpoint or any of the secondary endpoints.

Top 10 Value Stocks To Invest In 2018: Tenneco Inc.(TEN)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Shares of auto-part makers like Delphi Automotive (DLPH), BorgWarner (BWA), and Tenneco (TEN) are getting killed today, ostensibly due to an article in Automotive News. Wells Fargo’s Richard Kwas and team think Tesla Motors (TSLA) and its Model 3 deserve at least some of the blame:

Top 5 Stocks To Watch For 2018

Shutterstock

Over the course of its history, America has developed and maintained a good (if not ideal) cocktail of free markets and government, with each institution deployed in areas of society in which it excels.  It deploys free markets in allocating economic resources toward the production of private goods and services, and government in creating a “general equality of condition among the people,” as graphically described in Alexis De Tocqueville Democracy in America.

The government protects civil liberties and economic freedoms, and takes care of the “commons,” sectors of the economy where free markets are inadequate or fail altogether: the provision of public and semi-public goods, and the protection of the public from health, traffic, occupational, and environmental hazards.

Top 5 Stocks To Watch For 2018: Yanzhou Coal Mining Company Limited(YZC)

Advisors’ Opinion:

  • [By Lisa Levin]

    Thursday afternoon, energy shares slipped by just 0.1 percent. Meanwhile, top gainers in the sector included Superior Energy Services, Inc. (NYSE: SPN), and Yanzhou Coal Mining Co Ltd (ADR) (NYSE: YZC).

Top 5 Stocks To Watch For 2018: Coca-Cola Company (The)(KO)

Advisors’ Opinion:

  • [By Chris Lange]

    The Coca-Cola Co. (NYSE: KO) will share its latest quarterly earnings on Wednesday. The consensus estimates call for $0.58 in EPS and $9.65 billion in revenue. Shares ended last week at $45.03, in a 52-week range of $39.88 to $46.06. The consensus price target is $45.68.

  • [By Jayson Derrick]

    The Coca-Cola Co (NYSE: KO)’s bottom half of 2017 will be led by its new CEO James Quincey while the company will show “clearer evidence” of margin improvements and earnings per share upside as bottler re-franchising deals close.

  • [By Douglas A. McIntyre]

    Coke’s old CEO is out, and another Coca-Cola Co. (NYSE: KO) executive is in. That probably has little to do with Coke’s major problems, which will not be easy to solve. The first is a relentless drum beat from health experts about the dangers of sugar. As obesity and diabetes grow across most of the developed world, the old snacks are being replaced by healthier foods. In the emerging markets, slowing economies may undermine consumer spending. Coke has few large markets where it can turn to for growth.

  • [By The Ticker Tape]

    For more earnings coverage, check out what might be expected when McDonald's Corporation (NYSE: MCD) The Coca-Cola Co (NYSE: KO), and Chipotle Mexican Grill, Inc. (NYSE: CMG) report earnings tomorrow. Later in the week, tech titans Amazon.com, Inc. (NASDAQ: AMZN), Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL), Microsoft Corporation (NASDAQ: MSFT) and Intel Corporation (NASDAQ: INTC) report after market close on Thursday.

Top 5 Stocks To Watch For 2018: Tile Shop Hldgs, Inc.(TTS)

Advisors’ Opinion:

  • [By Lisa Levin]

    Tile Shop Hldgs, Inc. (NASDAQ: TTS) shares dropped 23 percent to $15.68 after the company reported downbeat Q2 results.

    Shares of Telefonaktiebolaget LM Ericsson (NASDAQ: ERIC) were down 16 percent to $6.09 after the company posted disappointing quarterly earnings. Ericsson posted Q2 operating loss of 1.2 billion Swedish crowns ($145.3 million), versus a year-ago profit of 2.8 billion Swedish crowns.

Top 5 Stocks To Watch For 2018: Cytokinetics, Incorporated(CYTK)

Advisors’ Opinion:

  • [By Chris Lange]

    Cytokinetics, Inc. (NASDAQ: CYTK) saw its shares take a massive step back in Tuesdays session after the firm reported negative results for its trial in amyotrophic lateral sclerosis (ALS). Specifically, the firms Phase 3 clinical trial of tirasemtiv did not meet the primary endpoint or any of the secondary endpoints.

  • [By Lisa Levin] Gainers
    Marathon Patent Group Inc (NASDAQ: MARA) shares surged 30.2 percent to $5.01 after dropping 40.86 percent on Tuesday. Marathon Patent Group filed for sale of 1.85 million shares of common stock by selling stockholders.
    Capricor Therapeutics Inc (NASDAQ: CAPR) shares jumped 17.2 percent to $2.25 after the company reported the FDA clearance of Investigational New Drug application for CAP-1002.
    Rite Aid Corporation (NYSE: RAD) gained 13.2 percent to $2.15 following 16.5 percent rally on Tuesday.
    Photronics, Inc. (NASDAQ: PLAB) shares climbed 11.8 percent to $10.45 after the company reported stronger-than-expected earnings for its fourth quarter.
    China Distance Education Hldgs Ltd (ADR) (NYSE: DL) shares surged 11.3 percent to $8.67. China Distance Education reported Q4 profit of $5.9 million on revenue of $41.7 million.
    Cytokinetics, Inc. (NASDAQ: CYTK) shares gained 11 percent to $8.05 after falling 7.05 percent on Tuesday.
    Ooma Inc (NYSE: OOMA) shares surged 8.5 percent to $10.85 as the company posted strong Q3 results.
    Nuance Communications Inc. (NASDAQ: NUAN) climbed 8 percent to $17.12 after the company reported stronger-than-expected results for its fourth quarter on Tuesday.
    American Superconductor Corporation (NASDAQ: AMSC) surged 7.8 percent to $3.59 after the company reported $8 million in D-VAR system orders.
    Thermon Group Holdings Inc (NYSE: THR) rose 6.3 percent to $24.17. William Blair upgraded Thermon Group from Market Perform to Outperform.
    Domino's Pizza, Inc. (NYSE: DPZ) surged 6.1 percent to $182.88. Nomura upgraded Domino's from Neutral to Buy.
    Xencor Inc (NASDAQ: XNCR) rose 5.9 percent to $21.17. Cantor Fitzgerald initiated coverage on Xencor with an Overweight rating.
    Idera Pharmaceuticals Inc (NASDAQ: IDRA) gained 5.1 percent to $2.28 after the company disclosed that it has been granted FDA Fast Track designation for IMO-2125.
    Regal Entertainment Group (NYSE: RGC) gained 5.1 percent to
  • [By Paul Ausick]

    Cytokinetics Inc. (NASDAQ: CYTK) dropped about 37% Tuesday to post a new 52-week low of $7.00 after closing at $11.10 on Monday. The 52-week high is $17.20. Volume was around 7 million, about 14 times the daily average of less than 500,000. The company’s ALS drug failed ti meet its endpoint in a phase 3 study.

  • [By Lisa Levin]

    Cytokinetics, Inc. (NASDAQ: CYTK) shares dropped 27 percent to $8.12 on the back of negative trial results for its amyotrophic lateral sclerosis, or ALS, treatment candidate tirasemtiv in a late-stage study. The results of the international Phase 3 study showed tiraemtive did not meet the primary endpoint of change from baseline in slow vital capacity, or SVS, evaluated at 24 weeks, as well the secondary endpoints evaluated at 48 weeks.

Top 5 Stocks To Watch For 2018: Roche Holding AG (RHHBY)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    As the graphic below shows, ImmunoGen’s product pipeline is potentially significant. Furthermore, it is impressive to see the involvement and partnerships in these early stage compounds by some of the world’s leading pharmaceutical and biotech companies. This includes firms like Amgen (NASDAQ:AMGN), Roche (OTCQX:RHHBY), Bayer (OTCPK:BAYRY), Sanofi (NYSE:SNY), Eli Lilly (NYSE:LLY), and Novartis (NYSE:NVS).

  • [By SEEKINGALPHA.COM]

    AstraZeneca’s forward EV/EBITDA (2017E) of 9.73 is lower than rivals like Novartis (NYSE:NVS) and Roche (OTCQX:RHHBY) (comparing companies with strong immune-oncology assets). The 10-year range for the company’s EV/EBITDA is 3.6 to 20.9. The dividend yield is also attractive at 4.6%.

  • [By SEEKINGALPHA.COM]

    Keytruda is also picking up indications, trading up Thursday on news of a new FDA approval in front line lung cancer treatment (not a big surprise, but there was some doubt). Some adverse news on Roche’s (OTCQX:RHHBY) I-O competitor Tecentriq in bladder cancer led IBD to publish this:

stock technical analysis

Source: ThinkstockMay 23, 2017: The S&P 500 closed higher on the day, up 0.2% at 2,398.45. Separately the DJIA closed up 0.2% as well at 20,938.59. The Nasdaq closed relatively flat at 6,138.71.

Although the broad markets had a positive day even if it was only slightly. Crude oil continued to push higher again on Tuesday back above $50 and now above $51. The main drag on the markets that kept them from pushing higher was retailers and a handful of tech stocks. Otherwise, the S&P 500 sectors were more or less positive across the board with a few exceptions. We saw the biggest gains in financial stocks and health care stocks. While crude was posting another strong day, oil & gas stocks were only slightly higher.

Crude oil broke the $50 level Monday and continued even higher on Tuesday. Crude was last trading higher on the day up 0.6% at $51.44.

stock technical analysis: Cytokinetics, Incorporated(CYTK)

Advisors’ Opinion:

  • [By Lisa Levin]

    Cytokinetics, Inc. (NASDAQ: CYTK) shares dropped 27 percent to $8.12 on the back of negative trial results for its amyotrophic lateral sclerosis, or ALS, treatment candidate tirasemtiv in a late-stage study. The results of the international Phase 3 study showed tiraemtive did not meet the primary endpoint of change from baseline in slow vital capacity, or SVS, evaluated at 24 weeks, as well the secondary endpoints evaluated at 48 weeks.

  • [By Chris Lange]

    Cytokinetics, Inc. (NASDAQ: CYTK) saw its shares take a massive step back in Tuesdays session after the firm reported negative results for its trial in amyotrophic lateral sclerosis (ALS). Specifically, the firms Phase 3 clinical trial of tirasemtiv did not meet the primary endpoint or any of the secondary endpoints.

  • [By Lisa Levin] Gainers
    Marathon Patent Group Inc (NASDAQ: MARA) shares surged 30.2 percent to $5.01 after dropping 40.86 percent on Tuesday. Marathon Patent Group filed for sale of 1.85 million shares of common stock by selling stockholders.
    Capricor Therapeutics Inc (NASDAQ: CAPR) shares jumped 17.2 percent to $2.25 after the company reported the FDA clearance of Investigational New Drug application for CAP-1002.
    Rite Aid Corporation (NYSE: RAD) gained 13.2 percent to $2.15 following 16.5 percent rally on Tuesday.
    Photronics, Inc. (NASDAQ: PLAB) shares climbed 11.8 percent to $10.45 after the company reported stronger-than-expected earnings for its fourth quarter.
    China Distance Education Hldgs Ltd (ADR) (NYSE: DL) shares surged 11.3 percent to $8.67. China Distance Education reported Q4 profit of $5.9 million on revenue of $41.7 million.
    Cytokinetics, Inc. (NASDAQ: CYTK) shares gained 11 percent to $8.05 after falling 7.05 percent on Tuesday.
    Ooma Inc (NYSE: OOMA) shares surged 8.5 percent to $10.85 as the company posted strong Q3 results.
    Nuance Communications Inc. (NASDAQ: NUAN) climbed 8 percent to $17.12 after the company reported stronger-than-expected results for its fourth quarter on Tuesday.
    American Superconductor Corporation (NASDAQ: AMSC) surged 7.8 percent to $3.59 after the company reported $8 million in D-VAR system orders.
    Thermon Group Holdings Inc (NYSE: THR) rose 6.3 percent to $24.17. William Blair upgraded Thermon Group from Market Perform to Outperform.
    Domino's Pizza, Inc. (NYSE: DPZ) surged 6.1 percent to $182.88. Nomura upgraded Domino's from Neutral to Buy.
    Xencor Inc (NASDAQ: XNCR) rose 5.9 percent to $21.17. Cantor Fitzgerald initiated coverage on Xencor with an Overweight rating.
    Idera Pharmaceuticals Inc (NASDAQ: IDRA) gained 5.1 percent to $2.28 after the company disclosed that it has been granted FDA Fast Track designation for IMO-2125.
    Regal Entertainment Group (NYSE: RGC) gained 5.1 percent to
  • [By Paul Ausick]

    Cytokinetics Inc. (NASDAQ: CYTK) dropped about 37% Tuesday to post a new 52-week low of $7.00 after closing at $11.10 on Monday. The 52-week high is $17.20. Volume was around 7 million, about 14 times the daily average of less than 500,000. The company’s ALS drug failed ti meet its endpoint in a phase 3 study.

stock technical analysis: Maximus, Inc.(MMS)

Advisors’ Opinion:

  • [By Michael Flannelly]

    Analysts at Jefferies initiated coverage on business process services provider Maximus Inc. (MMS) late on Thursday, giving the stock a bullish rating because it has several competitive advantages and should benefit from the Affordable Care Act (Obamacare).

    The analysts rate MMS as “Buy” and see shares reaching $47. This price target suggests a 20% upside to the stock’s Thursday closing price of $39.14.

    “MMS is a leading government outsourced contractor that produces consistently strong results,” Jefferies analyst David Styblo commented. “The company has several competitive advantages and is highly focused on health and human service projects. This positions MMS to enjoy multi-year growth from the ACA and other opportunities with limited risk. The company’s predictable business model, solid balance sheet, and EPS visibility into FY2014 also support a Buy and $47 PT.”

    Maximus shares were inactive during pre-market trading on Friday. The stock is up 23.83% year-to-date.

  • [By ]

    Maximus Inc (NYSE: MMS) holds just $16 million in long-term debt against $886 million in shareholder equity. Shares trade for 1.7 times sales for a discount of 26% on the industry average of 2.3 times sales.

stock technical analysis: NxStage Medical, Inc.(NXTM)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, healthcare shares dipped by 0.51 percent. Meanwhile, top losers in the sector included NxStage Medical, Inc. (NASDAQ: NXTM), down 8 percent, and Valeant Pharmaceuticals Intl Inc (NYSE: VRX), down 9 percent.

stock technical analysis: Vanda Pharmaceuticals Inc.(VNDA)

Advisors’ Opinion:

  • [By Roberto Pedone]

    Another biotechnology player that looks poised to trigger a big breakout trade is Vanda Pharmaceuticals (VNDA), which is focused on the development and commercialization of clinical-stage drug candidates for central nervous system disorders. This stock has been on fire so far in 2013, with shares up a whopping 258%.

    If you take a look at the chart for Vanda Pharmaceuticals, you’ll notice that this stock has recently broke out above some near-term overhead resistance levels at $12.34 to $12.66 a share with solid upside volume. So far, this breakout has held and now shares of VNDA are quickly moving within range of triggering an even bigger breakout trade.

    Traders should now look for long-biased trades in VNDA if it manages to break out above its 52-week high at $13.30 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action 908,467 shares. If that breakout hits soon, then VNDA will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $15 to $17 a share.

    Traders can look to buy VNDA off any weakness to anticipate that breakout and simply use a stop that sits right below some near-term support at $12 a share. One could also buy VNDA off strength once it takes out $13.30 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.

stock technical analysis: Pacira Pharmaceuticals, Inc.(PCRX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Pacira Pharmaceuticals Inc (NASDAQ: PCRX) shares were also up, gaining 17 percent to $39.80. Pacira Pharmaceuticals reported preliminary 2016 revenue of $276.4 million.

  • [By Chris Lange]

    Pacira Pharmaceuticals Inc. (NASDAQ: PCRX) has announced preliminary unaudited total revenues and net product sales for Exparel for the fourth quarter and the full year. Total revenues were $72.9 million and $276.4 million for the fourth quarter and full year, respectively. Exparel net product sales were $71.4 million and $239.9 million for the same periods, respectively. The consensus estimates from Thomson Reuters were calling for revenues of $72.56 million in the fourth quarter and $276.09 million in the full year.

Top Clean Energy Stocks To Buy Right Now

October 10, 2017: Markets opened higher again Tuesday but tech stocks weighed on the Nasdaq Composite by midday. There was no economic news of note today and the major earnings reports (from the big banks) aren’t due until Thursday morning. Utilities and consumer staples were the big gainers today while tech, materials, and consumer discretionary stocks lagged. WTI crude oil for November delivery settled at $50.92 a barrel, up about 2.7% on the day. December gold added 0.8% on the day to settle at $1,293.80. Equities were headed for a mixed close shortly before the bell as the DJIA traded up 0.24% for the day, the S&P 500 traded up 0.17%, and the Nasdaq Composite traded up 0.04%.

The Nasdaq Composite traded very near the break-even line just minutes before the closing bell. The closing tally could show either a small gain or a small loss for any of the indexes.

The DJIA stock posting the largest daily percentage gain ahead of the close Tuesday was Wal-Mart Stores Inc. (NYSE: WMT) which traded up 4.86% at $84.44. The stock’s 52-week range is $65.28 to $84.88 and the high was set this afternoon. Volume was more than 3 times the daily average of around 8.2 million shares. The company boosted guidance and revealed a $20 billion share buyback program at its investors’ day program today.

Top Clean Energy Stocks To Buy Right Now: QLT Inc.(QLTI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Tuesday afternoon, healthcare shares gained by 0.61 percent. Meanwhile, top gainers in the sector included Kindred Healthcare, Inc. (NYSE: KND), and QLT Inc. (USA) (NASDAQ: QLTI).

Top Clean Energy Stocks To Buy Right Now: Phillips 66(PSX)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    After facing several challenges last year, Phillips 66 (NYSE:PSX) enjoyed a bit of a bounce back in the first quarter. The refiner delivered expectation-smashing results, reporting an adjusted profit of $294 million, or $0.56 per share, which was a remarkable $0.51 per share ahead of the consensus estimate. Fueling the quarter were robust chemicals results and improving midstream earnings, which more than overcame continued weakness in the refining segment.

  • [By Paul Ausick]

    Phillips 66 (NYSE: PSX) said on Saturday that its operated Pasadena refined products terminal resumed truck loading and diesel loading is set to begin Sunday. Activities at the Mont Belvieu fractionator has been suspended due to a lack of available storage at the Mont Belvieu hub. The company is checking its Sweeny refinery (247,000 barrels a day) for damage and making repairs before resuming operations.

  • [By Shanthi Rexaline]

    The six companies that met the criterion are:

    Oshkosh Corp (NYSE: OSK). Phillips 66 (NYSE: PSX). SpartanNash Co (NASDAQ: SPTN). Suncor Energy Inc. (USA) (NYSE: SU). Washington Federal Inc. (NASDAQ: WAFD). Barnes & Noble, Inc. (NYSE: BKS).
    Oshkosh

    Oshkosh is a manufacturer of specialty vehicles and vehicle bodies and is based in Wisconsin. The company operates under four business segments, namely access equipment, defense, fire and emergency, and commercial.

  • [By WWW.THESTREET.COM]

    “As a technician, I see largely rangebound motion with big bounces being retraced and fades being bought at deep support,” she added. “As the markets opened, holding over $48.12 will likely spell a bullish run as several refineries are closed in the region, such as Phillips66 (PSX) , Shell Petrobras and Exxon (XOM) . The support tests that hold $47.3 will be buy zones more than likely. Overall, the current remains the same – a largely landlocked region with only temporary moves up or down until the rebalancing looks better.”

  • [By Matthew DiLallo, Tyler Crowe, and Jason Hall]

    Oil prices haven’t gotten off to the fast start many expected, falling around 6% on average during the first quarter of the year. That slump came despite OPEC’s best efforts since producing nations have achieved fairly good compliance on their planned output cuts. That said, despite the lackluster oil market, we still see some interestingopportunities in the oil market. Three stocks we really like right now are DistributionNOW(NYSE:DNOW),Phillips 66(NYSE:PSX), andConocoPhillips(NYSE:COP), which all should do well in the current oil market.

Top Clean Energy Stocks To Buy Right Now: PetroShare Corp. (PRHR)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Just one company joined the calendar, micro-cap gunshot detector ShotSpotter (Pending:SSTI), and one micro-cap company filed, DJ Basin E&P PetroShare (OTCQB:PRHR). We had expected more JOBS-Act filers this week as Monday marked the first day to file for companies preparing for post-Memorial Day launches.

Top Clean Energy Stocks To Buy Right Now: Yandex N.V.(YNDX)

Advisors’ Opinion:

  • [By Lee Jackson]

    Yandex N.V. (NASDAQ: YNDX) is the Google of Russia. It was very bold on the growing marketplace there, and its beta tests of a new back end have been very positive and should be rolled out soon. Deutsche Bank has a $38 price target, and the consensus is $40, in U.S. dollars.

  • [By WWW.GURUFOCUS.COM]

    For the details of Somerset Capital Management LLP’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Somerset+Capital+Management+LLP

    These are the top 5 holdings of Somerset Capital Management LLPFomento Economico Mexicano SAB de CV (FMX) – 1,268,818 shares, 36.15% of the total portfolio. Shares reduced by 9.36%Yandex NV (YNDX) – 3,352,412 shares, 25.48% of the total portfolio. Shares reduced by 3.61%ICICI Bank Ltd (IBN) – 5,074,899 shares, 13.19% of the total portfolio. Shares reduced by 11.08%Infosys Ltd (INFY) – 1,596,414 shares, 6.95% of the total portfolio. Shares reduced by 15.58%KT Corp (KT) – 1,330,431 shares, 6.41% of the

  • [By Monica Gerson]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Monday’s regular session.

    Pier 1 Imports Inc (NYSE: PIR) Dec16 5.0 Puts Sweep: 1191 @ ASK $0.80: 1354 traded vs 102 OI: $5.32 Ref
    Alcoa Inc (NYSE: AA) Jul16 9.5 Puts Sweep: 1494 @ ASK $0.13: 14k traded vs 6682 OI: $10.09 Ref
    Sarepta Therapeutics Inc (NASDAQ: SRPT) Jul16 10.0 Puts: 3536 @ ASK $0.50: 5506 traded vs 54k OI: Earnings 8/4 $22.50 Ref
    Tableau Software Inc (NYSE: DATA) Jul16 47.5 Puts Sweep: 837 @ ASK $0.30: 995 traded vs 37 OI: Earnings 8/3 $50.60 Ref
    Yandex NV (NASDAQ: YNDX) Aug16 18.0 Puts Sweep: 532 @ ASK $0.30: 2143 traded vs 78 OI: Earnings 7/28 Before Open $22.02 Ref
    Wolverine World Wide, Inc. (NYSE: WWW) Aug16 22.5 Puts: 719 @ ASK $1.35: 1032 traded vs 0 OI: Earnings 7/19 $22.22 Ref
    Conn's Inc (NASDAQ: CONN) Jan17 5.0 Puts Sweep: 605 @ ASK $0.85: 1355 traded vs 3132 OI: $7.16 Ref

    Posted-In: Huge Put PurchasesNews Options Markets

  • [By Peter Graham]

    A long term performance chart shows Alphabet Inc being in a relatively steadyuptrend compared withsearch engine peerslike Yahoo! Inc (NASDAQ: YHOO), China basedBaidu Inc (NASDAQ: BIDU) and Russiafocused mid cap Yandex NV (NASDAQ: YNDX):

  • [By Steve Symington]

    Yandex N.V.(NASDAQ:YNDX)announced exceptional first-quarter 2017 results on Thursday, highlighted by a recent antitrust deal with Google, stabilizing market share in its core search segment, and strong growth from its various other business units.

Top Clean Energy Stocks To Buy Right Now: Cytokinetics, Incorporated(CYTK)

Advisors’ Opinion:

  • [By Chris Lange]

    Cytokinetics, Inc. (NASDAQ: CYTK) saw its shares take a massive step back in Tuesdays session after the firm reported negative results for its trial in amyotrophic lateral sclerosis (ALS). Specifically, the firms Phase 3 clinical trial of tirasemtiv did not meet the primary endpoint or any of the secondary endpoints.

  • [By Lisa Levin]

    Cytokinetics, Inc. (NASDAQ: CYTK) shares dropped 27 percent to $8.12 on the back of negative trial results for its amyotrophic lateral sclerosis, or ALS, treatment candidate tirasemtiv in a late-stage study. The results of the international Phase 3 study showed tiraemtive did not meet the primary endpoint of change from baseline in slow vital capacity, or SVS, evaluated at 24 weeks, as well the secondary endpoints evaluated at 48 weeks.

  • [By Lisa Levin] Gainers
    Marathon Patent Group Inc (NASDAQ: MARA) shares surged 30.2 percent to $5.01 after dropping 40.86 percent on Tuesday. Marathon Patent Group filed for sale of 1.85 million shares of common stock by selling stockholders.
    Capricor Therapeutics Inc (NASDAQ: CAPR) shares jumped 17.2 percent to $2.25 after the company reported the FDA clearance of Investigational New Drug application for CAP-1002.
    Rite Aid Corporation (NYSE: RAD) gained 13.2 percent to $2.15 following 16.5 percent rally on Tuesday.
    Photronics, Inc. (NASDAQ: PLAB) shares climbed 11.8 percent to $10.45 after the company reported stronger-than-expected earnings for its fourth quarter.
    China Distance Education Hldgs Ltd (ADR) (NYSE: DL) shares surged 11.3 percent to $8.67. China Distance Education reported Q4 profit of $5.9 million on revenue of $41.7 million.
    Cytokinetics, Inc. (NASDAQ: CYTK) shares gained 11 percent to $8.05 after falling 7.05 percent on Tuesday.
    Ooma Inc (NYSE: OOMA) shares surged 8.5 percent to $10.85 as the company posted strong Q3 results.
    Nuance Communications Inc. (NASDAQ: NUAN) climbed 8 percent to $17.12 after the company reported stronger-than-expected results for its fourth quarter on Tuesday.
    American Superconductor Corporation (NASDAQ: AMSC) surged 7.8 percent to $3.59 after the company reported $8 million in D-VAR system orders.
    Thermon Group Holdings Inc (NYSE: THR) rose 6.3 percent to $24.17. William Blair upgraded Thermon Group from Market Perform to Outperform.
    Domino's Pizza, Inc. (NYSE: DPZ) surged 6.1 percent to $182.88. Nomura upgraded Domino's from Neutral to Buy.
    Xencor Inc (NASDAQ: XNCR) rose 5.9 percent to $21.17. Cantor Fitzgerald initiated coverage on Xencor with an Overweight rating.
    Idera Pharmaceuticals Inc (NASDAQ: IDRA) gained 5.1 percent to $2.28 after the company disclosed that it has been granted FDA Fast Track designation for IMO-2125.
    Regal Entertainment Group (NYSE: RGC) gained 5.1 percent to
  • [By Paul Ausick]

    Cytokinetics Inc. (NASDAQ: CYTK) dropped about 37% Tuesday to post a new 52-week low of $7.00 after closing at $11.10 on Monday. The 52-week high is $17.20. Volume was around 7 million, about 14 times the daily average of less than 500,000. The company’s ALS drug failed ti meet its endpoint in a phase 3 study.

Mid-Afternoon Market Update: Dow Gains 180 Points; DSW Shares Drop On Earnings Miss

Toward the end of trading Tuesday, the Dow traded up 0.77 percent to 23,611.66 while the NASDAQ climbed 0.95 percent to 6,855.20. The S&P also rose, gaining 0.67 percent to 2,599.38.

Leading and Lagging Sectors

Tuesday afternoon, the technology sector proved to be a source of strength for the market. Leading the sector was strength from Cray Inc. (NASDAQ: CRAY) and Mellanox Technologies, Ltd. (NASDAQ: MLNX).

In trading on Tuesday, utilities shares rose by just 0.3 percent. Meanwhile, top losers in the sector included Signet Jewelers Ltd. (NYSE: SIG), down 28 percent, and DSW Inc. (NYSE: DSW) down 12 percent.

Top Headline

Lowe's Companies, Inc. (NYSE: LOW) reported better-than-expected results for its third quarter.

Lowe's reported Q3 earnings of $1.05 per share on revenue of $16.77 billion. However, analysts were expecting a profit of $1.03 per share on sales of $16.59 billion. Its comparable sales gained 5.7 percent during the quarter.

The company named Richard D. Maltsbarger as Chief Operating Officer.

Equities Trading UP

Celsion Corporation (NASDAQ: CLSN) shares shot up 49 percent to $3.18. Oppenheimer analyst Hartaj Singh initiated coverage on the company with an Outperform rating and $9 price target.

Shares of Cheetah Mobile Inc (ADR) (NYSE: CMCM) got a boost, shooting up 17 percent to $12.70 after the company posted strong quarterly earnings.

Cubic Corporation (NYSE: CUB) shares were also up, gaining 15 percent to $61.45. Cubic reported Q4 net income of $13.2 million, after posting a loss in the year-ago period. Cubic also disclosed that it has been selected for contract from Boston MBTA to deliver next-generation fare payment system.

Equities Trading DOWN

Cytokinetics, Inc. (NASDAQ: CYTK) shares dropped 27 percent to $8.12 on the back of negative trial results for its amyotrophic lateral sclerosis, or ALS, treatment candidate tirasemtiv in a late-stage study. The results of the international Phase 3 study showed tiraemtive did not meet the primary endpoint of change from baseline in slow vital capacity, or SVS, evaluated at 24 weeks, as well the secondary endpoints evaluated at 48 weeks.

Shares of Signet Jewelers Ltd. (NYSE: SIG) were down 28 percent to $54.60 after the company reported a Q3 GAAP loss of $0.20 per share and lowered its FY 2018 earnings guidance.

DSW Inc. (NYSE: DSW) was down, falling around 13 percent to $19.75 as the company posted weaker-than-expected Q3 earnings and lowered its earnings forecast for the year.

Commodities

In commodity news, oil traded up 0.57 percent to $56.74 while gold traded up 0.54 percent to $1,282.20.

Silver traded up 0.91 percent Tuesday to $17.095, while copper rose 1.06 percent to $3.1485.

Eurozone

European shares closed mostly higher today. The eurozone’s STOXX 600 surged 0.44 percent, the Spanish Ibex Index fell 0.32 percent, while Italy’s FTSE MIB Index gained 0.62 percent. Meanwhile the German DAX gained 0.83 percent, and the French CAC 40 climbed 0.48 percent while U.K. shares rose 0.30 percent.

Economics

The Chicago Fed National Activity Index increased to 0.65 in October, versus a reading of 0.36 in September.

The Johnson Redbook Retail Sales Index declined 0.7 percent during the first three weeks of November versus October.

Existing-home sales rose 2 percent at an annual rate of 5.48 million in October. Economists projected a 5.42 million pace.

Federal Reserve Chair Janet Yellen is set to speak in New York at 6:00 p.m. ET.

Mid-Afternoon Market Update: Dow Gains 180 Points; DSW Shares Drop On Earnings Miss

Toward the end of trading Tuesday, the Dow traded up 0.77 percent to 23,611.66 while the NASDAQ climbed 0.95 percent to 6,855.20. The S&P also rose, gaining 0.67 percent to 2,599.38.

Leading and Lagging Sectors

Tuesday afternoon, the technology sector proved to be a source of strength for the market. Leading the sector was strength from Cray Inc. (NASDAQ: CRAY) and Mellanox Technologies, Ltd. (NASDAQ: MLNX).

In trading on Tuesday, utilities shares rose by just 0.3 percent. Meanwhile, top losers in the sector included Signet Jewelers Ltd. (NYSE: SIG), down 28 percent, and DSW Inc. (NYSE: DSW) down 12 percent.

Top Headline

Lowe's Companies, Inc. (NYSE: LOW) reported better-than-expected results for its third quarter.

Lowe's reported Q3 earnings of $1.05 per share on revenue of $16.77 billion. However, analysts were expecting a profit of $1.03 per share on sales of $16.59 billion. Its comparable sales gained 5.7 percent during the quarter.

The company named Richard D. Maltsbarger as Chief Operating Officer.

Equities Trading UP

Celsion Corporation (NASDAQ: CLSN) shares shot up 49 percent to $3.18. Oppenheimer analyst Hartaj Singh initiated coverage on the company with an Outperform rating and $9 price target.

Shares of Cheetah Mobile Inc (ADR) (NYSE: CMCM) got a boost, shooting up 17 percent to $12.70 after the company posted strong quarterly earnings.

Cubic Corporation (NYSE: CUB) shares were also up, gaining 15 percent to $61.45. Cubic reported Q4 net income of $13.2 million, after posting a loss in the year-ago period. Cubic also disclosed that it has been selected for contract from Boston MBTA to deliver next-generation fare payment system.

Equities Trading DOWN

Cytokinetics, Inc. (NASDAQ: CYTK) shares dropped 27 percent to $8.12 on the back of negative trial results for its amyotrophic lateral sclerosis, or ALS, treatment candidate tirasemtiv in a late-stage study. The results of the international Phase 3 study showed tiraemtive did not meet the primary endpoint of change from baseline in slow vital capacity, or SVS, evaluated at 24 weeks, as well the secondary endpoints evaluated at 48 weeks.

Shares of Signet Jewelers Ltd. (NYSE: SIG) were down 28 percent to $54.60 after the company reported a Q3 GAAP loss of $0.20 per share and lowered its FY 2018 earnings guidance.

DSW Inc. (NYSE: DSW) was down, falling around 13 percent to $19.75 as the company posted weaker-than-expected Q3 earnings and lowered its earnings forecast for the year.

Commodities

In commodity news, oil traded up 0.57 percent to $56.74 while gold traded up 0.54 percent to $1,282.20.

Silver traded up 0.91 percent Tuesday to $17.095, while copper rose 1.06 percent to $3.1485.

Eurozone

European shares closed mostly higher today. The eurozone’s STOXX 600 surged 0.44 percent, the Spanish Ibex Index fell 0.32 percent, while Italy’s FTSE MIB Index gained 0.62 percent. Meanwhile the German DAX gained 0.83 percent, and the French CAC 40 climbed 0.48 percent while U.K. shares rose 0.30 percent.

Economics

The Chicago Fed National Activity Index increased to 0.65 in October, versus a reading of 0.36 in September.

The Johnson Redbook Retail Sales Index declined 0.7 percent during the first three weeks of November versus October.

Existing-home sales rose 2 percent at an annual rate of 5.48 million in October. Economists projected a 5.42 million pace.

Federal Reserve Chair Janet Yellen is set to speak in New York at 6:00 p.m. ET.

what is share market

11 Sales Pitches That Kill Sales

5 Reasons Genworth’s Would-Be Buyer Could Still Close the Deal

ACA Healthy Enrollee Bills Pound Aetna and Kaiser: Mark Farrah

The Treasury bill yield curve says the probability that the U.S. government won’t raise the debt ceiling in time to avert a technical default — a failure to make an interest payment on time — is about 15%.

That’s based on a simple formula that looks at the elevated yields on bills that mature around the time the government is expected to exhaust its borrowing authority in mid-October, compared with the yields on bills due before and after.

Copyright 2017 Bloomberg. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

You are signed up!

ThinkAdvisor’s TechCenter is an educational resource designed to give you a competitive edge by keeping you abreast of new tech innovations and need-to-know information that can be applied to your business. padding: 0px 81px;width: inherit; Retirement Wire

Your resource for news, research and analysis to help you deliver more effective outcomes to your clients. Resources Guide: How One Advisor Turned $3k into $15M in 9 Months

Kick-start your practice with one advisor’s winning formula.

what is share market: Kona Grill Inc.(KONA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Kona Grill Inc (NASDAQ: KONA) was down, falling around 25 percent to $2.00 after the company reported downbeat quarterly results.

    Commodities

what is share market: Cytokinetics, Incorporated(CYTK)

Advisors’ Opinion:

  • [By Lisa Levin]

    Cytokinetics, Inc. (NASDAQ: CYTK) shares dropped 27 percent to $8.12 on the back of negative trial results for its amyotrophic lateral sclerosis, or ALS, treatment candidate tirasemtiv in a late-stage study. The results of the international Phase 3 study showed tiraemtive did not meet the primary endpoint of change from baseline in slow vital capacity, or SVS, evaluated at 24 weeks, as well the secondary endpoints evaluated at 48 weeks.

  • [By Paul Ausick]

    Cytokinetics Inc. (NASDAQ: CYTK) dropped about 37% Tuesday to post a new 52-week low of $7.00 after closing at $11.10 on Monday. The 52-week high is $17.20. Volume was around 7 million, about 14 times the daily average of less than 500,000. The company’s ALS drug failed ti meet its endpoint in a phase 3 study.

  • [By Chris Lange]

    Cytokinetics, Inc. (NASDAQ: CYTK) saw its shares take a massive step back in Tuesdays session after the firm reported negative results for its trial in amyotrophic lateral sclerosis (ALS). Specifically, the firms Phase 3 clinical trial of tirasemtiv did not meet the primary endpoint or any of the secondary endpoints.

what is share market: Bridgford Foods Corporation(BRID)

Advisors’ Opinion:

  • [By Lisa Levin]

    Non-cyclical consumer goods & services sector was the top gainer in the US market on Tuesday. Top gainers in the sector included Nature's Sunshine Prod. (NASDAQ: NATR), Bridgford Foods Corporation (NASDAQ: BRID), and SunOpta, Inc. (USA) (NASDAQ: STKL).

  • [By Lisa Levin]

    In trading on Friday, non-cyclical consumer goods & services shares rose by just 0.3 percent. Meanwhile, top losers in the sector included Medifast Inc (NYSE: MED), down 5 percent, and Bridgford Foods Corporation (NASDAQ: BRID), down 6 percent.

what is share market: Opko Health Inc(OPK)

Advisors’ Opinion:

  • [By Demitrios Kalogeropoulos]

    As for individual stocks, Cabela’s (NYSE:CAB) and Opko Health (NASDAQ:OPK) stood out by posting greater price declines than the broader market.

    Opko Health fails a trial

    Opko Health shares slumped 19% after the biotech announced disappointing results for one of its most advanced clinical trials. The human growth hormone injection, coded as hGH-CTP, failed to produce a statistically significant improvement over a placebo pill in its phase 3 study.

  • [By WWW.THESTREET.COM]

    In the Lightning Round, Cramer was bullish on Kohlberg Kravis Roberts (KKR) , Opko Health (OPK) and Allergan (AGN) .

    Cramer was bearish on Kimberly-Clark (KMB) , Novartis AG (NVS) , Chemours (CC) and Gulfport Energy (GPOR) .

  • [By Cory Renauer]

    Shares of multinational pharmaceutical and diagnostics companyOpko Health, Inc. (NASDAQ:OPK)are feeling the heat after reporting fourth-quarter and full-year 2016 earnings. Despite a major thumping late last year, the stock gave up another 10.5% as of 3:31 p.m. on Thursday.

  • [By Paul Ausick]

    Opko Health Inc. (NASDAQ: OPK) dropped about 11.7% Wednesday to post a new 52-week low of $6.65 after closing at $7.53 on Tuesday. The stock’s 52-week high is $12.15. Volume of more than 15 million was nearly 4 times the daily average of around 4 million shares traded. On Tuesday the company reported a first-quarter loss.

  • [By Paul Ausick]

    Opko Health Inc. (NASDAQ: OPK) dropped about 3.6% Monday to post a new 52-week low of $6.37 after closing at $6.61 on Friday. The stock’s 52-week high is $12.15. Volume was about 25% higher than the daily average of around 4.6 million shares. The company had no specific news.

what is share market: Sunoco LP(SUN)

Advisors’ Opinion:

  • [By Lisa Levin]

    Friday afternoon, the non-cyclical consumer goods & services sector proved to be a source of strength for the market. Leading the sector was strength from Ballard Power Systems Inc. (USA) (NASDAQ: BLDP) and Sunoco LP (NYSE: SUN).

  • [By Lisa Levin]

    Here is the list of stocks going ex-dividend on August 3, 2016.

    J B Hunt Transport Services Inc (NASDAQ: JBHT) – $0.2200 dividend, 1.0791 percent yield
    Johnson Controls Inc (NYSE: JCI) – $0.2900 dividend, 2.6250 percent yield
    FirstEnergy Corp. (NYSE: FE) – $0.3600 dividend, 3.9680 percent yield
    Sunoco LP (NYSE: SUN) – $0.8255 dividend, 10.7347 percent yield
    Wells Fargo & Co (NYSE: WFC) – $0.3800 dividend, 3.1588 percent yield
    BP plc (ADR) (NYSE: BP) – $0.6000 dividend, 6.8768 percent yield
    American Airlines Group Inc (NASDAQ: AAL) – $0.1000 dividend, 1.1442 percent yield
    Heidrick & Struggles International, Inc. (NASDAQ: HSII) – $0.1300 dividend, 2.9834 percent yield
    Alcoa Inc (NYSE: AA) – $0.0300 dividend, 1.1321 percent yield
    Sensient Technologies Corporation (NYSE: SXT) – $0.2700 dividend, 1.5341 percent yield

    Posted-In: Ex-DividendNews Dividends Markets Trading Ideas

  • [By Douglas A. McIntyre]

    Exxon Mobil Corp. (NYSE: XOM) is the second largest company in America and the world’s largest oil company. Chevron Corp. (NYSE: CVX) is the third largest company in the United States. Valero Corp. (NYSE: VLO) is among the world’s largest refiners. Sunoco L.P. (NYSE: SUN) is one of North America’s largest owners of stations and convenience stores. BP PLC (NYSE: BP) is among the world’s oil behemoths. Shell is the U.S. branch of oil giant Royal Dutch Shell PLC (NYSE: RDS-A).

what is share market: Evoke Pharma, Inc.(EVOK)

Advisors’ Opinion:

  • [By Cameron Saucier]

    Evoke (Nasdaq: EVOK) is a pharmaceutical company that develops drug candidates intended to treat gastrointestinal diseases. EVOK rose 73% last month after it announced positive guidance from the FDA for Gimoti, a patented nasal delivery drug that is intended to treat gastroparesis in adult women. The positive results were from a second pre-NDA (New Drug Application) meeting Evoke had with the FDA. EVOK is currently trading at $2.67 per share and is down 9.83% as of Jan. 9 YOY.

  • [By Lisa Levin]

     

    Losers
    DBV Technologies SA – ADR (NASDAQ: DBVT) shares tumbled 50.6 percent to $23.73 after the company disclosed that its peanut allergy trial failed to meet primary endpoint.
    Connecture Inc (NASDAQ: CNXR) shares declined 40.8 percent to $0.290. Connecture reported that it will voluntarily delist from the NASDAQ for OTCQX Market.
    Walter Investment Management Corp (NYSE: WAC) slipped 19.2 percent to $0.410. On Friday, Walter Investment Management disclosed that it has reached an agreement with term lenders and senior noteholders on financial restructuring.
    Eldorado Gold Corp (USA) (NYSE: EGO) shares dropped 15.9 percent to $1.83. Eldorado Gold lowered its production guidance for its Kisladag operation.
    Seanergy Maritime Holdings Corp. (NASDAQ: SHIP) shares fell 15.4 percent to $1.04.
    Future Fintech Group Inc (NASDAQ: FTFT) dropped 13.6 percent to $1.53. Future FinTech reported filing of proxy statement, including proposal for corporate restructuring.
    Concordia International Corp (NASDAQ: CXRX) shares fell 12.3 percent to $0.500 after dipping 38.71 percent on Friday.
    Aemetis Inc (NASDAQ: AMTX) shares declined 11.3 percent to $0.550
    OncoSec Medical Inc (NASDAQ: ONCS) dipped 10.5 percent to $1.12. OncoSec reported a $7.1 million registered direct at-the-market offering at a price of $1.34375 per share.
    Evoke Pharma Inc (NASDAQ: EVOK) shares fell 10.35 percent to $3.08 after the company disclosed 'positive' topline results from comparative exposure pharmacokinetic study for Gimoti.
    Eiger Biopharmaceuticals Inc (NASDAQ: EIGR) shares dropped 9.4 percent to $11.60 as the company disclosed Phase 2 interim 24-week data with pegylated interferon lambda in Hepatitis Delta Virus infection at the American Association for the Study of Liver Diseases Meeting.
    Viking Therapeutics Inc (NASDAQ: VKTX) shares slipped 6.6 percent to $2.80. Viking Therapeutics presented results from proof-of-concept study of VK0214 in in vivo

etf trading

Undocumented immigrants in New York who can’t afford a lawyer and are facing deportation will soon have access to free legal counsel.

The New York governor’s office said last week that it is allocating $10 million in its fiscal 2018 budget toward creating a legal defense fund “to ensure all immigrants, regardless of residency status, have access to representation.”

Unlike U.S. citizens, undocumented immigrants don’t have the right to free legal counsel.

Called the Liberty Defense Project, the funding is part of a public-private partnership with the Carnegie Corporation of New York and the Ford Foundation. So far, the non-profit organizations have contributed $1.5 million, making the total funds available $11.5 million.

“During these stormy times, it’s critical that all New Yorkers have access to their full rights under the law,” New York Governor Andrew Cuomo said when he first announced the program.

The Liberty Defense Project will work with 182 advocacy groups and legal entities to provide attorneys to immigrants.

etf trading: Noah Holdings Ltd.(NOAH)

Advisors’ Opinion:

  • [By Monica Gerson]

    Noah Holdings Limited (ADR) (NYSE: NOAH) is estimated to post financial results for its latest quarter.

    Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets

etf trading: Insys Therapeutics, Inc.(INSY)

Advisors’ Opinion:

  • [By Sean Williams]

    Shares of Insys Therapeutics (NASDAQ:INSY), a biopharmaceutical company that develops medicines to treat pain and other supportive-care products, tumbled by as much as 11% during Wednesdays trading session before recovering to finish lower by less than 2%. The reason for the volatile trading can probably be traced to carryover from the company’s first-quarter earnings release before the opening bell on Tuesday.

  • [By Keith Speights]

    Insys Therapeutics (NASDAQ:INSY) already won U.S. regulatory approval fordronabinol solution Syndros in treatingchemotherapy-induced nausea and vomiting (CINV) and anorexia in patients with AIDS. The company is preparing to launch Syndros soon.

  • [By Ashley Moore]

    We’ve compiled a list of the most heavily shorted stocks to show you which stocks have the most negative sentiment on the market…

    Company Name (Ticker)Short FloatShare PriceHanwha Q Cells Co. Ltd. (Nasdaq ADR: HQCL)98.52%$ 8.88Renren Inc. (NYSE: RENN)91.59%$ 8.53Weight Watchers International Inc. (NYSE: WTW)67.92%$12.57INSYS Therapeutics Inc. (Nasdaq: INSY)66.71%$10.74Twilio Inc. (NYSE: TWLO)66.34%$33.17Nutanix Inc. (Nasdaq: NTNX)65.65%$31.96Fitbit Inc. (NYSE: FIT)55.15%$ 6.06Weibo Corp. (Nasdaq ADR: WB)53.83%$55.26RPC Inc. (NYSE: RES)53.62%$21.19Straight Path Communications Inc. (NYSEMKT: STRP)49.27%$34.79Momo Inc. (Nasdaq ADR: MOMO)48.63%$26.80Seritage Growth Properties (NYSE: SRG)46.91%$44.87Lannett Company Inc. (NYSE: LCI)45.46%$23.00Gogo Inc. (Nasdaq: GOGO)43.98%$ 9.10Altisource Portfolio Solutions SA (Nasdaq: ASPS)42.78%$22.73Cheetah Mobile Inc. (NYSE ADR: CMCM)40.86%$10.00

    Some investors think the only way to profit from the stock market is to buy stocks and wait for the price to rise. However, these investors are missing out on the massive profit opportunity that comes from shorting stocks.

  • [By William Patalon III]

    Insys Therapeutics Inc. (NASDAQ: INSY) – our “War on Pain” biotech play – has given us a profit of more than 16% since we recommended the stock just two weeks ago.

etf trading: Diamondrock Hospitality Company(DRH)

Advisors’ Opinion:

  • [By Monica Gerson]

    DiamondRock Hospitality Company (NYSE: DRH) is projected to post its quarterly earnings at $0.18 per share on revenue of $218.42 million.

    Weyerhaeuser Co (NYSE: WY) is expected to report its quarterly earnings at $0.20 per share.

etf trading: Cytokinetics, Incorporated(CYTK)

Advisors’ Opinion:

  • [By Chris Lange]

    Cytokinetics, Inc. (NASDAQ: CYTK) saw its shares take a massive step back in Tuesdays session after the firm reported negative results for its trial in amyotrophic lateral sclerosis (ALS). Specifically, the firms Phase 3 clinical trial of tirasemtiv did not meet the primary endpoint or any of the secondary endpoints.

  • [By Paul Ausick]

    Cytokinetics Inc. (NASDAQ: CYTK) dropped about 37% Tuesday to post a new 52-week low of $7.00 after closing at $11.10 on Monday. The 52-week high is $17.20. Volume was around 7 million, about 14 times the daily average of less than 500,000. The company’s ALS drug failed ti meet its endpoint in a phase 3 study.

  • [By Lisa Levin]

    Cytokinetics, Inc. (NASDAQ: CYTK) shares dropped 27 percent to $8.12 on the back of negative trial results for its amyotrophic lateral sclerosis, or ALS, treatment candidate tirasemtiv in a late-stage study. The results of the international Phase 3 study showed tiraemtive did not meet the primary endpoint of change from baseline in slow vital capacity, or SVS, evaluated at 24 weeks, as well the secondary endpoints evaluated at 48 weeks.